Sign in
4

Changes in Ownership

Keros Therapeutics, Inc. Filed Acc 0001209191-21-037790

Options or other derivatives

  • Director acquired 8,293 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Farzan Nima Director 2021-06-01 Grant or award · Stock Option (right to buy) +8,293 8,293 D: show line 1 in the form
Loading xslF345X03/doc4.xml…